Paediatric Insomnia Disorder
Approved paediatric pharmacological options for insomnia are limited in Europe and absent in the USA and Canada. CBT-I is recommended as first-line therapy but may be hard to access or apply in some children. Paediatric insomnia disorder i…
1 sources - 4 claims
Approved paediatric pharmacological options for insomnia are limited in Europe and absent in the USA and Canada. CBT-I is recommended as first-line therapy but may be hard to access or apply in some children. Paediatric insomnia disorder involves sleep initiation, sleep maintenance, or early awakening problems with impaired daytime functioning. Paediatric insomnia is associated with school, behavioural, quality-of-life, and family burdens.